Financial Synergies Wealth Advisors, Inc. Pfizer Inc Transaction History

Financial Synergies Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $33,165 - $38,084	1,281 Added 100.23%	2,559 $71 Million
Q4 2023 Apr 04, 2024	SELL	$26.13 - $33.94 $39,952 - $51,894	-1,529 Reduced 54.47%	1,278 $65.5 Million
Q3 2023 Apr 04, 2024	BUY	$32.09 - $37.51 $16,686 - $19,505	520 Added 22.74%	2,807 $93.1 Million
Q2 2023 Apr 04, 2024	SELL	$36.12 - $41.79 $4,009 - $4,638	-111 Reduced 4.63%	2,287 $83.9 Million
Q1 2023 Apr 04, 2024	BUY	$39.39 - $51.28 $44,116 - $57,433	1,120 Added 87.64%	2,398 $97.8 Million
Q4 2022 Apr 04, 2024	BUY	$41.75 - $54.5 $11,606 - $15,151	278 Added 27.8%	1,278 $65.5 Million
Q2 2022 Apr 04, 2024	BUY	$46.53 - $55.17 $46,530 - $55,170	1,000 New	1,000 $52.4 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.